liquiritigenin has been researched along with Breast Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Baggett, S; Bjeldanes, LF; Chow, S; Cohen, I; Leitman, DC; Levy, N; Mersereau, JE; Ricke, WA; Staub, RE; Tagliaferri, M; Zogovic, T; Zogric, T | 1 |
| Bolton, JL; Chen, SN; Dietz, BM; Dong, H; Ellis, SG; Hajirahimkhan, A; Lankin, DC; Mbachu, O; Nikolic, D; Pauli, GF; Simmler, C; van Breemen, RB | 1 |
| Chen, JZ; Khan, MZI; Nazli, A; Uzair, M | 1 |
| Besch-Williford, C; Hyder, SM; Liang, Y | 1 |
| Bartom, ET; Bolton, JL; Chen, SN; Clare, SE; Dietz, BM; Dong, H; Hajirahimkhan, A; Howell, C; Khan, SA; Lantvit, DD; Pauli, GF; Xuei, X | 1 |
| Hawse, JR; Shanle, EK; Xu, W | 1 |
| Häring, J; Lattrich, C; Ortmann, O; Schüler, S; Stegerer, A; Treeck, O | 1 |
1 review(s) available for liquiritigenin and Breast Neoplasms
| Article | Year |
|---|---|
An overview on Estrogen receptors signaling and its ligands in breast cancer.
Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ligands; Male; Receptors, Estrogen | 2022 |
6 other study(ies) available for liquiritigenin and Breast Neoplasms
| Article | Year |
|---|---|
Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Flavanones; Glycyrrhiza; Humans; Mice; Mice, Nude; Nuclear Receptor Coactivator 2; Selective Estrogen Receptor Modulators; Transcription, Genetic; Transfection; Uterus; Xenograft Model Antitumor Assays | 2008 |
Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication.
Topics: Breast Neoplasms; Chalcones; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Flavones; Glycyrrhiza; Humans; Plant Extracts | 2018 |
The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth.
Topics: Animals; Benzophenones; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholesterol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Flavanones; Humans; Mice; Mice, Nude; Xenograft Model Antitumor Assays | 2022 |
Breast cancer prevention with liquiritigenin from licorice through the inhibition of aromatase and protein biosynthesis in high-risk women's breast tissue.
Topics: Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogen Receptor beta; Estrogens; Female; Glycyrrhiza; Humans; Protein Biosynthesis | 2023 |
Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.
Topics: Antineoplastic Agents; Apigenin; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Flavanones; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Ligands; Luciferases | 2011 |
Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines.
Topics: Alternative Splicing; Androstane-3,17-diol; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Dose-Response Relationship, Drug; Estrogen Receptor beta; Female; Flavanones; Gene Expression Regulation, Neoplastic; Humans; Time Factors | 2013 |